Can software guide surgeons to the best treatment order for liver metastases?

NCT ID NCT07760558

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial evaluates a decision-support software designed to help surgeons choose the optimal sequence of treatments for colorectal cancer that has spread to the liver. Surgeons will review simulated patient cases, first making a treatment plan on their own, then seeing the software's recommendation and deciding whether to change their plan. The study measures how often decisions change, decision confidence, time taken, and user experience. The goal is to see if the software improves consistency and supports surgical reasoning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Decision-support software for surgical sequencing
What this could lead to
If effective, this software could help surgeons make more consistent and informed decisions about the order of treatments for colorectal liver metastases, potentially improving patient outcomes.
What could go wrong
This is a small simulation study with only 12 surgeons, so results may not reflect real-world practice. The software's recommendations may not always align with clinical judgment or improve actual patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL LIVER METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.